| __timestamp | ADMA Biologics, Inc. | BioCryst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 7461000 |
| Thursday, January 1, 2015 | 6745968 | 13047000 |
| Friday, January 1, 2016 | 8494742 | 11253000 |
| Sunday, January 1, 2017 | 18092835 | 13933000 |
| Monday, January 1, 2018 | 22502922 | 29514000 |
| Tuesday, January 1, 2019 | 25910757 | 37121000 |
| Wednesday, January 1, 2020 | 35050817 | 67929000 |
| Friday, January 1, 2021 | 42896889 | 118818000 |
| Saturday, January 1, 2022 | 52458024 | 159371000 |
| Sunday, January 1, 2023 | 59020000 | 213894000 |
Data in motion
In the competitive world of biotechnology, managing operational expenses is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of ADMA Biologics, Inc. and BioCryst Pharmaceuticals, Inc. over a decade, from 2014 to 2023.
ADMA Biologics, Inc. has seen a steady increase in SG&A expenses, growing from approximately $4.8 million in 2014 to nearly $59 million in 2023. This represents a staggering 1,125% increase, reflecting the company's expansion and investment in administrative capabilities.
On the other hand, BioCryst Pharmaceuticals, Inc. started with $7.5 million in 2014 and reached over $213 million by 2023, marking a 2,755% rise. This significant growth underscores BioCryst's aggressive scaling and strategic investments in its operational infrastructure.
Understanding these trends provides valuable insights into how these companies allocate resources to support their growth strategies.
SG&A Efficiency Analysis: Comparing Novartis AG and ADMA Biologics, Inc.
SG&A Efficiency Analysis: Comparing Incyte Corporation and ADMA Biologics, Inc.
Cost Management Insights: SG&A Expenses for Viatris Inc. and BioCryst Pharmaceuticals, Inc.
Walgreens Boots Alliance, Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Exelixis, Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Exelixis, Inc. vs BioCryst Pharmaceuticals, Inc.
ADMA Biologics, Inc. vs Protagonist Therapeutics, Inc.: SG&A Expense Trends
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and BioCryst Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Arrowhead Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.
ImmunityBio, Inc. vs BioCryst Pharmaceuticals, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Travere Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.